Park I Seul, Son Mijeong, Ma Hyun Woo, Kim Jihyung, Kim Da Hye, Kim Seung Won, Cheon Jae Hee
Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.
Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.
Intest Res. 2021 Jul;19(3):349-353. doi: 10.5217/ir.2020.00075. Epub 2020 Nov 2.
The safety and effectiveness of adalimumab was demonstrated in a phase 3 trial in Japanese patients with intestinal Behçet's disease. The aim of this study was to evaluate the long-term safety and effectiveness of adalimumab in Japanese patients with intestinal Behçet's disease.
阿达木单抗的安全性和有效性在一项针对日本肠道白塞病患者的3期试验中得到了证实。本研究的目的是评估阿达木单抗在日本肠道白塞病患者中的长期安全性和有效性。